Medication info
Twin Down Tablet 40/5 mg

Twin Down Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
It is a biconvex oval double tablet, white and light gray.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201804760 · Approved 2018.11.29 · Insurance code 622803350

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this drug; however, if blood pressure is not controlled with the individual components as described below, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a fixed-dose combination containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this drug with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication helps lower blood pressure more effectively when patients with essential hypertension cannot achieve sufficient blood pressure control with either amlodipine or telmisartan alone. The combination of these two drugs acts to dilate blood vessels and manage blood pressure stably. This contributes to reducing the risk of cardiovascular complications and maintaining health. Therefore, this medication is used for essential hypertension that is not controlled with amlodipine and telmisartan monotherapy.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this drug; however, if blood pressure is not controlled with the individual components as described below, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a fixed-dose combination containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this drug with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters. Therefore, it must not be used by women who are pregnant or may become pregnant. If pregnancy is confirmed, use should be discontinued immediately, and if necessary, it should be replaced with other safe medications. This medication is contraindicated in patients with certain conditions. For example, individuals allergic to any component of this medication, pregnant women, breastfeeding women, patients with biliary obstruction, severe liver impairment, severe heart diseases, severe hypotension, patients in shock, unstable heart failure after acute myocardial infarction, and certain kidney diseases cannot use this medication. Moreover, patients with primary aldosteronism, certain heart valve diseases, weakened liver function, gastrointestinal diseases, renal artery hypertension, patients undergoing dialysis, and the elderly must use this medication with caution, requiring dose adjustments or close monitoring by a physician. This medication can commonly cause side effects such as dizziness and peripheral edema, while rare side effects may include fainting or serious heart issues. If side effects are suspected, immediate consultation with a healthcare professional is necessary. Drug interactions should also be monitored carefully. Caution is required when taken with other antihypertensive medications, certain diuretics, potassium supplements, lithium, digoxin, warfarin, grapefruit juice, etc., and regular monitoring of kidney function and serum potassium levels is critical. It is safest for pregnant or breastfeeding women not to use this medication, and it should also be avoided during breastfeeding. The safety and efficacy of this medication have not been established for pediatric patients under 18 years of age, so its use is not recommended. In elderly patients, doses should be adjusted gradually and used with caution, as overdose may lead to hypotension, heart problems, or kidney damage, requiring immediate medical attention. This medication should be kept out of reach of children and should be opened just before use as it is sensitive to moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • sensory abnormalities
  • sensory loss
  • taste abnormalities
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • sweating
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • vascular edema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • micturition disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container to avoid exposure to light and air. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

It is a biconvex oval double tablet, white and light gray.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.